Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-549-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Read Across from Desmodur N3300:
Subchronic study: NOAEC: 3.3 mg/m³ (rat, 90 d, local)
Subacute study: NOAEC: 4.3 mg/m³ (rat, 3 weeks, local)
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEC
- 3.3 mg/m³
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- reliable
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
As no repeated-dose data are available for the registered substance, read-across from Desmodur N 3300 is used:
A subacute inhalation toxicity study (3 weeks) according to OECD TG 412 was conducted on 10 test animals per sex and dose group. In this study the animals were head/nose exposed to the aerosolised substance (5days/week, 6h/day) at concentrations of 4.3, 14.7, and 89.8 mg. The aerosol was of adequate respirability for the rats.
No substance induced mortality was observed in the course of the study. Clinical signs occurred for the mid and the high dose groups only. These included bloody noses of slight to moderate intensity; reduced motility on the first two exposure days and for males reduced body weight gain were observed for the high dose group only (89.8 mg/m³). As the symptoms diminished within the course of the study an adaptive effect must have occurred for the rats.
At necropsy increased lung weights were seen at dose group 14.7 mg/m³ and above. Histopathological examinations revealed especially for animals exposed to 89.8 mg/m³ inflammatory changes in the lung and hyperaemia with detritus of the nose mucosa. These effects were unspecific and most probably related to the irritant properties of the substance.
No other target organs than the respiratory tract were affected.
Thus, the NOAEL of this study was 4.3 mg/m³.
A subchronic inhalation toxicity study (90 days) according to OECD TG 413 was conducted on 10 test animals per sex and dose group. In this study animals were head/nose exposed to the aerosolised substance (5 days/week, 6h/day) at concentrations of 0 (vehicle control), 0.5, 3.3, and 26.4 mg/m³. The aerosol was of adequate respirability for the rats (MMAD approx. 1.5 µm, GSD approx. 1.4.). Investigations also included lung function measurements after acetylcholine challenge towards the end of the study.
No substance induced mortality was observed in the course of the study.
All animals tolerated the treatment virtually without symptoms, except
one male of the high dose group (26.4 mg/m³) that exhibited laboured
breathing. A slightly reduced body weight gain was observed for the male
rats of the 26.4 mg/m³ group towards the end of the study. Body weight
gain was not affected for female animals. Lung function tests provided
indications of a chronic obstructive lung disorder in rats of the 26.4
mg/m³ group.
The absolute and relative lung weights were significantly increased in
male and female rats of the 26.4 mg/m³ dose group. Histopathologically,
inflammatory changes in the respiratory tract (focal fibrosis,
proliferation of connective tissue, and increase in macrophages) were
seen in the 26.4 mg/m³ dose group and haematological investigations
revealed increased leukocyte counts in the same dose group. Other
haematological, clinical chemistry and urine analysis parameters
remained unchanged.
Conclusively, all tests and examinations provided evidence that changes
were confined to the respiratory tract of rats repeatedly exposed to
26.4 mg/m³. The location of the damage was essentially limited to the
lung periphery. All changes were nonspecific and are thus attributed to
the primary irritant potential of the test substance. There were no
indications for damages to organs except for the respiratory tract.
The NOAEL of this study was 3.3 mg/m³.
Justification for classification or non-classification
According to Regulation (EC) No 1272/2008, Annex I, no classification is warranted for repeated dose toxicity. Classification as STOT repeated is not justified, due to lack of cumulative toxicity. As it could be shown, no systemic effects were observed in the repeated dose studies. The local effects observed did not give evidence for a major time-dependent change of the response threshold, as the NOAECs were 3.3 mg/m³ for the subchronic key study (concentrations tested 0, 0.5, 3.3, 26.4 mg/m³) and 4.3 mg/m³ for a subacute (3 weeks) study (concentrations tested 0, 4.3, 14.7, 89.8 mg/m³). Moreover, there is scientific evidence that for non-volatile polyisocyanates that act predominantly as pulmonary irritants even the NOAECs from acute pulmonary irritant potency studies, where bronchoalveolar lavage endpoints as markers for pulmonary irritation were investigated (recommended in the Technical Rule for Hazardous Substances 430, published by the German Federal Ministry of Labour and Social Affairs), does not essentially differ from NOAECs of long(er)-term repeated inhalation studies (Pauluhn, Journal of Applied Toxicology, 24, 231-247, 2004). In fact, the NOAEC of the pulmonary irritant potency study revealed a NOAEC for the substance of 3 mg/m³.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.